QuickView for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9E1B4939F78E3E99513BEFDCAAEE7BF%3Bjsessionid%3D0D3DBCFC8B84ADDE75E42324D8084A8D%3Bjsessionid%3D3EFD0032CB15AA01F0040163408157F0%3Bjsessionid%3D7D16C35F2459D7EAE6FAF343D45E87E2%3Bjsessionid%3DA2D230611F1E046DB5C8825168919750%3Bjsessionid%3D378AC201390097514A957D9BC431B475%3Bjsessionid%3D2B73A413660A8C3236E60470B884FA89%3Bjsessionid%3D3282D3769701B61C9B4631F9FE8DD502%3Bjsessionid%3DEA99BE169C085C8FC268BAE887FB9097%3Bjsessionid%3DCC92FC8CD04F870DA0D899714F749332%3Bjsessionid%3DD83CD4D0F08C1274C781471A91406472%3Bjsessionid%3D5D6897E966586D8726B920EEC80A6443%3Bjsessionid%3D3AE2809CE33DDC86464588537C7008BE%3Bjsessionid%3D4451FB5F4101D65970AB253E3E276006%3Bjsessionid%3D8176E976DCC6B9B5AD25A00E184A6A18%3Bjsessionid%3DA8199FADA74C99FBA29F9A55E35CFD8B (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9E1B4939F78E3E99513BEFDCAAEE7BF%3Bjsessionid%3D0D3DBCFC8B84ADDE75E42324D8084A8D%3Bjsessionid%3D3EFD0032CB15AA01F0040163408157F0%3Bjsessionid%3D7D16C35F2459D7EAE6FAF343D45E87E2%3Bjsessionid%3DA2D230611F1E046DB5C8825168919750%3Bjsessionid%3D378AC201390097514A957D9BC431B475%3Bjsessionid%3D2B73A413660A8C3236E60470B884FA89%3Bjsessionid%3D3282D3769701B61C9B4631F9FE8DD502%3Bjsessionid%3DEA99BE169C085C8FC268BAE887FB9097%3Bjsessionid%3DCC92FC8CD04F870DA0D899714F749332%3Bjsessionid%3DD83CD4D0F08C1274C781471A91406472%3Bjsessionid%3D5D6897E966586D8726B920EEC80A6443%3Bjsessionid%3D3AE2809CE33DDC86464588537C7008BE%3Bjsessionid%3D4451FB5F4101D65970AB253E3E276006%3Bjsessionid%3D8176E976DCC6B9B5AD25A00E184A6A18%3Bjsessionid%3DA8199FADA74C99FBA29F9A55E35CFD8B